Our Location

Address:
                         360 East Midway Road,
                      Fort Pierce, FL 34982
 
                          Phone: (772)-595-9830

Midway Research Center

Midway Research Center’s primary objective is to improve the treatment options of the community by giving the community access to cutting edge treatment and the latest in pharmaceutical research. Many patients who cannot afford medications, or who are no longer responding to their medicines have gained access to necessary medical treatments that are either too expensive or not yet commercially available.

The research leaders at Midway Research Center has given more than 500 patients access to free and advanced medical treatment and an improved medication regimen that has ensured a better quality of life. By participating in these clinical trials, it is also the company’s goal to help the medical community continuously gather pertinent information about diseases. We believe that it is only through continuous education and research that we can only fully understand the disease, which will hopefully lead us to the ultimate goal – a cure.

Led by Moti Ramgopal, MD, FACP, FIDSA, and Brenda Jacobs, DNP, ARNP, AAHIVS, Midway Research Center currently completed more than 250 clinical trials, involving Phase I to Phase IV, ranging from HIV studies, to infectious diseases treatments that gave more than $5,000,000 in care to patients. These studies involved every new HIV Treatment Drug to enter the market in the past decade.

Our approach

Currently Enrolling Clinical Trials

Enrollment Closed: Trial Active

Past Research

Testing

Read latest publications

 

Rapid Initiation of Symtuza for HIV Treatment Shows Promise

https://www.mdmag.com/medical-news/rapid-initiation-symtuza-hiv-treatment-shows-promise 

 

DIAMOND study: 48-week results show long-term efficacy of Symtuza

https://www.healio.com/infectious-disease/hiv-aids/news/online/%7B4c410d0d-df13-416a-96a4-ced3c7e73ab0%7D/diamond-study-48-week-results-show-long-term-efficacy-of-symtuza 

 

Janssen Presents New Data From First Phase 3 Trial Of Single-Tablet Regimen In Rapid Initiation Model Of Care Demonstrating Safety, Efficacy With Symtuza Through 48 Weeks

“Without research, we can’t discover new medicines and advanced clinical technologies or uncover new methods of detecting and treating disease.  Research is critical to advancing the quality of care we offer. “
DR. MOTI RAMGOPAL, MIDWAY RESEARCH CERTIFIED PRINCIPAL INVESTIGATOR

Discover The Future

We are a multi-disciplinary research facility committed to focussed and efficient drug discovery

Contact Us